Latest Reports

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Retina Editions. These editions are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors’ evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Refractive Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

The Ophthalmic Market Trends: Quarterly US Glaucoma Editions deliver essential, data-driven insights into the US glaucoma surgery market. These reports, based on quarterly surveys of glaucoma surgeons, provide a comprehensive analysis of key metrics such as patient diagnoses, treatment regimens, medication usage, surgical procedure volumes, and emerging trends in MIGS, canal-based procedures, and investigational treatments. With in-depth trend analysis, full-year forecasts, and year-over-year comparisons, these editions equip you with the latest information on product adoption, market share, and treatment strategies, ensuring you make informed, strategic decisions in the glaucoma treatment landscape.

Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Cataract Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

The “2025 Single-Use Ophthalmic Surgical Products Market Report” delivers a comprehensive analysis of global and regional markets for disposable ophthalmic surgical products—spotlighting key trends, growth drivers, and strategic opportunities shaping the field. 

The report details market performance and outlook across all major product categories—including viscoelastics, knives, disposable instruments, balanced salt solutions, procedure packs, drapes, sutures, fluid management devices, ocular dyes, capsular tension rings, eye shields, and cautery pencils—and profiles 26 leading companies, highlighting their products, positioning, and future strategies. 

The “2025 Ophthalmic OR Microscopes Market Report” delivers a focused and in-depth analysis of the global market for ophthalmic operating room microscopes. As a specialized supplement to Market Scope’s “2025 Ophthalmic Diagnostic Equipment Market Report,” it offers unmatched insight needed to understand dynamics, evaluate growth opportunities, and benchmark performance within this market. 

The report provides a comprehensive overview of the devices, segmenting the market into basic, standard, and advanced microscope models. For each segment, it presents detailed estimates of unit sales, installed base, and average selling prices, along with profiles of the leading manufacturers shaping the competitive landscape. 

The “2025 Optical Coherence Tomography Market Report” delivers an in-depth, data-driven assessment of the global OCT imaging landscape and the forces reshaping it. The report analyzes clinical, technological, and competitive dynamics across all major OCT segments, providing a clear view of what’s driving adoption today and how the market will evolve over the next five years. 

Market performance is forecast across six distinct product categories—basic OCT, advanced OCT, combination OCT/fundus systems, combination OCT/SLO systems, intraoperative OCT, and OCTA. For each, the report provides estimates of unit sales, installed base trends, and average selling prices. 

The report also profiles 13 leading OCT manufacturers, examining their product portfolios, innovation strategies, competitive positioning, and future outlooks to provide a comprehensive understanding of the companies shaping the future of this market. 

The “2025 Exudative Retinal Disease Pharmaceuticals Market Report” delivers a comprehensive analysis of anti-VEGFs and other therapies for exudative retinal diseases. It highlights key market trends, growth drivers, and future opportunities, with five-year forecasts in units and dollars for branded ocular anti-VEGFs, cancer drugs used off-label, biosimilars, and sustained-drug-delivery devices. The report also breaks down market share by product category and profiles 29 leading competitors, detailing their products, strategies, and market positioning. 

The “2025 Premium Cataract Surgery Market Report” delivers a clear view of the world’s leading PCS markets, covering 13 countries that together generate 84 percent of global PCS manufacturer revenue. From the United States and China to Japan, Germany, and beyond, each market is analyzed in depth, highlighting key trends, growth drivers, and strategic opportunities. 

The report zeroes in on the factors that matter most for companies evaluating market potential or planning to launch premium cataract surgery devices, providing actionable insights to guide investment and expansion decisions.